Pharma Patent Valuation

Roberto Moro-Visconti ()
Additional contact information
Roberto Moro-Visconti: Catholic University of the Sacred Heart
Authors registered in the RePEc Author Service: Roberto Moro Visconti

Chapter Chapter 11 in Augmented Corporate Valuation, 2022, pp 389-417 from Springer

Abstract: Abstract The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, intending to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy, and marketing of drugs. In the pharmaceutical industry, the patent protection of drugs and medicines is accorded particular importance, because drugs and medicines can easily be copied or imitated (by analyzing a pharmaceutical substance) and because of the significant research and development spending and the high risks associated with the development of a new drug. The healthcare industry is also very sensitive and hyper-regulated. The analysis of the business model is a prerequisite for its appraisal. The evaluation depends on the prioritizing identification of the crucial value drivers.

Keywords: BioTech; MedTech; Startups; Real options; Know-how; Discounted Cash Flows (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-030-97117-5_11

Ordering information: This item can be ordered from
http://www.springer.com/9783030971175

DOI: 10.1007/978-3-030-97117-5_11

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().